{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:24:50Z","timestamp":1792113890060,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00381-017-3352-y","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T01:52:25Z","timestamp":1488333145000},"page":"849-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Second re-irradiation for DIPG progression, re-considering \u201cold strategies\u201d with new approaches"],"prefix":"10.1007","volume":"33","author":[{"given":"Andres","family":"Morales La Madrid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Santa-Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Cruz Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Puerta Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Guillen Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Su\u00f1ol Capella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"de Torres Gomez-Pallete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Lassaletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normand","family":"Laperriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Vill\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"3352_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol. 2:205","journal-title":"Front Oncol."},{"issue":"1","key":"3352_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11060-014-1448-8","volume":"119","author":"NJ Robison","year":"2014","unstructured":"Robison NJ, Kieran MW (2014) Diffuse intrinsic pontine glioma: a reassessment. J Neuro-Oncol 119(1):7\u201315","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"3352_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/COC.0b013e318201a2b7","volume":"35","author":"HP Fontanilla","year":"2012","unstructured":"Fontanilla HP, Pinnix CC, Ketonen LM et al (2012) Palliative reirradiation for progressive diffuse intrinsic pontine glioma. Am J Clin Oncol 35(1):51\u201357","journal-title":"Am J Clin Oncol"},{"key":"3352_CR4","doi-asserted-by":"crossref","unstructured":"Massimino M, Biassoni V, Miceli R, Schiavello E 2014 Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neuroncol 305\u201312","DOI":"10.1007\/s11060-014-1428-z"},{"issue":"9","key":"3352_CR5","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/pbc.25045","volume":"61","author":"M Porkholm","year":"2014","unstructured":"Porkholm M, Valanne L, L\u00f6nnqvist T et al (2014) Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 61(9):1603\u20131609","journal-title":"Pediatr Blood Cancer"},{"key":"3352_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fonc.2015.00147","volume":"5","author":"P Buczkowicz","year":"2015","unstructured":"Buczkowicz P, Hawkins C (2015) Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma. Front Oncol 5:147","journal-title":"Front Oncol"},{"key":"3352_CR7","doi-asserted-by":"crossref","unstructured":"Puget BS, Blauwblomme T, Grill J (2012) Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma? Am Soc Clin Oncol Educ Book 629\u201333","DOI":"10.14694\/EdBook_AM.2012.32.59"},{"issue":"10","key":"3352_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","volume":"31","author":"S Puget","year":"2015","unstructured":"Puget S, Beccaria K, Blauwblomme T et al (2015) Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Childs Nerv Syst 31(10):1773\u20131780","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"3352_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet Nature Publishing Group 46(5):451\u2013456","journal-title":"Nat Genet Nature Publishing Group"},{"issue":"5","key":"3352_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso AM, Papillon-Cavanagh S et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46(5):462\u2013466","journal-title":"Nat Genet"},{"issue":"3","key":"3352_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124(3):439\u2013447","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3352_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C et al (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46(5):457\u2013461","journal-title":"Nat Genet"},{"issue":"7","key":"3352_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827a","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(7):827","journal-title":"Nat Med"},{"key":"3352_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fonc.2015.00148","volume":"5","author":"A Morales La Madrid","year":"2015","unstructured":"Morales La Madrid A, Kieran MW, Hashizume R (2015) Future clinical trials in DIPG: bringing epigenetics to the clinic. Front Oncol 5:148","journal-title":"Front Oncol"},{"issue":"1","key":"3352_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2014.01.013","volume":"111","author":"MS Zaghloul","year":"2014","unstructured":"Zaghloul MS, Eldebawy E, Ahmed S et al (2014) Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiother Oncol 111(1):35\u201340","journal-title":"Radiother Oncol"},{"key":"3352_CR16","doi-asserted-by":"publisher","unstructured":"Negretti L, Bouchireb K, Levy-Piedbois C, et al. Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. J Neuro-Oncol. 2011 ; 104(3):773\u2013777.","DOI":"10.1007\/s11060-011-0542-4"},{"issue":"2","key":"3352_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijrobp.2012.04.006","volume":"85","author":"GO Janssens","year":"2013","unstructured":"Janssens GO, Jansen MH, Lauwers SJ et al (2013) Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol Biol Phys 85(2):315\u2013320","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3352_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11060-011-0677-3","volume":"106","author":"JE Wolff","year":"2012","unstructured":"Wolff JE, Rytting ME, Vats TS et al (2012) Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience. J Neuro-Oncol 106(2):391\u2013397","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"3352_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-013-1189-0","volume":"114","author":"S Jackson","year":"2013","unstructured":"Jackson S, Patay Z, Howarth R et al (2013) Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma. J Neuro-Oncol 114(3):339\u2013344","journal-title":"J Neuro-Oncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-017-3352-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-017-3352-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-017-3352-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T02:58:38Z","timestamp":1601693918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-017-3352-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3352"],"URL":"https:\/\/doi.org\/10.1007\/s00381-017-3352-y","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}